Embryonic ectoderm is fated to become either neural or epidermal, depending on patterning processes that occur before and during gastrulation. It has been stated that epidermal commitment proceeds from a bone morphogenetic protein-4 (BMP-4)-dependent inhibition of dorsal ectoderm neuralization. We recently demonstrated that murine embryonic stem (ES) cells treated with BMP-4 undergo effective keratinocyte commitment and epidermogenesis. Focusing on the precise role of BMP-4 in the early choice between neural and epidermal commitment, we show here that BMP-4 treatment of ES cells leads to a dramatic apoptotic death of Sox-1 þ neural precursors with concomitant epidermal engagement. In addition, neutralization of the Smad pathway prevents both the BMP-4 apoptotic process and the inhibition of neural differentiation. Our results suggest that, in mammals, BMP-4, as an active inducer of epidermal commitment, interferes with the survival of neural precursors through induction of their apoptotic cell death.
Introduction
During vertebrate gastrulation, cells derived from the ectoderm are segregated into neural or epidermal primordia depending on signals delivered from the organizer tissue. Both ectoderm and mesoderm are patterned along the dorsoventral (DV) axis, governed by the morphogenetic and instructive effect of bone morphogenetic proteins (BMPs) (for a review, see Hogan. 1 ) BMP-4, a member of the transforming growth factor-beta (TGF-b) superfamily, is a morphogen that is secreted early during the late blastula stage by the ventral embryonic region. It promotes the specification of ventral cell fates, and its action is counterbalanced by the secretion of dorsal antagonists (Noggin, Chordin, Follistatin), leading to a DV axis gradient of functional BMP-4 (for a review, see Hogan 1 ) . At the ectodermal level, BMP-4 behaves like a strong epidermal inducer in regions with low antagonist concentrations (ventral region of the ectoderm), while high levels of BMP-4 antagonists in the dorsal region induce the formation of the neuroectoderm during Xenopus development and probably more generally in vertebrate development. 2, 3 For the ectoderm, this indirect and inhibitory mode of the dorsal organizer action is described in the 'neural default' model, according to which ectodermal cells will undergo neural differentiation unless instructed by BMPs not to do so, and to become epidermal. 2 Numerous studies in Xenopus laevis support this 'default' model to explain the neural cell fate determination. In mammals, little experimental data are available regarding the mechanisms underlying early neural and ectodermal differentiation. 4 Gene deletion experiments in mouse embryos have not been conclusive regarding the role of BMP and its antagonists in such a commitment. However, differentiation of mouse embryonic stem (ES) cells appears to be a potent in vitro model to study embryonic neural induction in mammals. A high level of neural differentiation has been obtained through aggregation of ES cells with retinoic acid treatment in the presence of serum, 5 or by the coculture of ES cells with the PA6 stromal cell line in the absence of serum. 6 In both cases, the addition of BMP-4 suppressed neural differentiation in a time-dependent manner, while it promoted mesodermal 5 or ectodermal engagement. 6 The attenuation of BMP signaling in ES cells appears to be essential but not sufficient for neural induction, since its specific blockade does not significantly promote neural differentiation, suggesting that some additional signals are required for mammalian neural induction. Recent data have shown that, in the absence of feeder-derived or serum-derived factors and at low cell densities, ES cells undergo a direct phenotypic change towards the neural fate, 7 a process that requires autocrine fibroblast growth factor (FGF). 8 Nevertheless, BMP-4 appears to be the central mediator in the switch from neuronal to epidermal commitment. The target genes regulated by the BMP signaling pathway and their roles during the specification of ventral cell types are poorly understood. The homeobox Msx gene family is known to be activated by BMP signals during morphogenesis and cell differentiation. Among them, the Msx-1 transcription factor has been shown to mediate the BMP signaling in epidermal induction and inhibition of neural differentiation in Xenopus development. 9 However, the mechanism leading to inhibition of early neural cell fate determination through the interaction of BMP-4 with the neuroectoderm is not known.
Several lines of evidence suggest that the activity of BMPs is associated with developmentally regulated apoptosis. 10, 11 In particular, BMP-4 triggers apoptosis in prospective neural crest cells, 12 in the dorsal portion of the chick optic cup during morphogenesis of the eye 13 and in the interdigital space of the developing limbs in birds. 14 Similarly, BMP responses lead to apoptosis of committed populations of neural stem cells isolated from progressively older fetuses, and then to neuronal and finally glial differentiation. 15, 16 We recently reported the ability of BMP-4 to efficiently promote murine ES cell differentiation towards epidermal fate and skin organogenesis in vitro. 17 In the present study, we show that a high proportion of ES cells, engaged in differentiation towards neural cell types, undergo a dose-and timedependent apoptotic cell death when treated early with BMP-4. This apoptotic cell death involves the characteristic mitochondrial damages leading to the cleavage of caspase-3 and targets early neural Sox-1 positive precursor cells. We further demonstrate that this mechanism does not involve the p38 MAP kinase pathway usually associated with BMP proapoptotic effects, 18 but proceeds rather through the activation of both the Smad pathway and Msx1/2 gene expression. Altogether, our results indicate that part of the inhibition of neuralization by BMP-4, in mammals, involves the apoptotic cell death of neural precursor cells, resulting in enrichment of epithelial/epidermal lineages.
Results

BMP-4 inhibits the differentiation of mouse ES cells into neural precursors and promotes epidermal commitment
Neuronal differentiation of ES cells was induced using a protocol described elsewhere. 6 Seeded on fixed fibroblastic feeder cells in the absence of serum, mouse ES cells differentiated efficiently within 7 days into neural precursors, Figure  1A (i)). As expected, virtually all colonies were immunoreactive to neural markers at day 6 (Table 1 and Figure S1 ), and at day 4 of differentiation, 80% of the colonies were already positive for the neural precursor marker Sox-1 (Table 1 and Figure S1 ). Neuronal commitment of ES cells was confirmed at the level of gene expression with the detection of Sox-1 and MAP-2 transcripts at day 4 ( Figure 1B ). The absence of glial (Sox10, GFAP) markers confirmed the requirement of appropriate culture conditions to induce astrocytic (GFAP) and oligodendrocytic (Sox10) differentiation within this in vitro culture model. 6, 19 Furthermore, no differentiation toward endodermal (AFP) and mesodermal (brachyury) lineages was observed ( Figure 1B) .
A drastic morphological change in the cell culture was observed when the differentiated ES cells were treated from day 3 to day 6 with BMP-4 (0.5 nM). Typically, the large colonies of cells acquired an epithelial phenotype instead of the axonal morphology observed in the absence of BMP-4 treatment. This modification was already evident at day 7 (not shown), and it was completed by day 11 ( Figure 1A (b) ). Accordingly, rare NeuN, Neurofilament and b-III-tubulin-positive cells were detected, by immunofluorescence, following BMP-4 treatment ( Figure 1A (f, h, j) ). On the other hand, when the cell cultures were further extended for two additional days in the presence of 10% bovine serum, large patches of cytokeratin K14-positive cells became apparent ( Figure 1A (l) ).
A quantitative illustration of this effect could be reported by intra-cellular staining and flow cytometric analysis. The proportion of Neurofilament-positive cells measured at day 7 and 11 of differentiation was largely decreased upon BMP-4 treatment from day 3 to day 6, while the proportion of cytokeratin K18-positive epithelial cells was enhanced ( Figure 1C ). This culture model confirms the dual role of BMP-4 in the differentiation process of mouse ES cells: it can induce a sharp inhibition of the neural engagement while promoting the epidermal commitment.
Msx-1, -2 and Id-3 are early transcription factors known to be induced in response to BMP-4 the course of ES cell differentiation. Total RNAs were extracted 0, 2 and 24 h after BMP-4 treatment and were tested for Msx-1, Msx-2 and Id3 expression by real-time PCR ( Table 2 ). The results showed that their expression is rapidly activated upon BMP-4 treatment. At 24 h post-treatment, the transcriptional enhancement was drastic for Msx-1 and Msx-2 genes, but was declining for Id-3.
These results are consistent with the role of BMP-4 and Msx expression in epidermal induction and inhibition of neural differentiation, at least as demonstrated in Xenopus. low /PI À cells were both largely increased (from 6 to 16%, and from 20 to 48% respectively) (Figure 2b ). The induction of cell death was dose-dependent, with a maximal effect at known physiologic doses of BMP-4 (0.5 nM) (Figure 2c ). It also required de novo protein synthesis, since the mitochondrial damage induced by BMP-4 on differentiated ES cells was completely blocked by the use of 10 mM cycloheximide ( Figure S2 ).
The specific proteolytic activation of caspases, from the zymogen proform to the active cleaved enzyme, is one of the hallmarks of apoptosis. As mitochondrial damage leads to caspase activation, we tested the effect of caspase inhibition on BMP-4 induced cell death. When cells were preincubated for 4 h with z-VAD-fmk, a broad specific inhibitor of caspases, the resulting loss of live cells induced by overnight treatment with BMP-4 remained unchanged (28.0% with z-VAD-fmk pretreatment versus 31.3% in the control) ( Table 3) . On the contrary, the increase in PI þ dead cells resulting from BMP-4 treatment was significantly reduced when a caspase inhibitor was used (4.3% with z-VAD-fmk pretreatment versus 23.2% in the control). Alternatively, the increase in cells with reduced DCm yet not undergoing degradation of their plasma membrane (cells undergoing apoptosis and not dead cells) was increased (32.8% with z-VAD-fmk pretreatment versus 12.9% in the control). These results showed that, in our experimental conditions, BMP-4 treatment induced the activation of caspases, a mechanism that was required for entire cell death process. Futhermore, it emphasizes that the 
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caspase activation occurs downstream of mitochondrial injury.
Caspase-3 is an effector caspase that is thought to be a key executioner protease of apoptosis. During ES cell differentiation, a proportion of cells spontaneously died by apoptosis as illustrated by significant caspase-3 activation in untreated cells (Figure 2d ). However, the amount of cleaved caspase-3 increased significantly after 12 h of BMP-4 treatment, with a peak of cleavage at 14 h (Figure 2d ). The amount of procaspase-3 slightly decreased over time, with a minimum amount remaining at 18 h, suggesting that the pool had not been renewed or the levels were not sufficient to cover the activation from the procaspase form to the cleaved caspase-3. Finally, we also observed externalization of phosphatidylserine, as well as sub-G1 fragmentation of DNA (not shown) confirming the induction of apoptosis after BMP-4 treatment.
The p38 signaling pathway is not involved in the apoptotic process induced by BMP-4
Several lines of evidence link the TGF-b superfamily and the p38 MAP kinase signaling pathways, through the TAK1 MAPKKKinase 20 and its activator TAB1. 21 Some of the apoptotic effects of BMPs have been shown to involve the activation of p38. 18, 22, 23 In our cell system, we were unable to The Smad signaling pathway is required for both the inhibition of neural commitment and the apoptosis of neural precursor cells induced by BMP-4
The intracellular Smad proteins are signaling molecules that act in the transduction of signaling pathways triggered by members of the TGF-b family. Oligomerization of the BMP-4 receptors leads to the phosphorylation of Smad-1, which, in turn, associates with Smad-4. This multimeric complex translocates to the nucleus where it can specifically activate the transcription of numerous genes. One endogenous inhibitor of this pathway is the Smad-6 protein, which on the one hand can prevent the phosphorylation of Smad-1 by the BMP receptors, 24 and on the other can associate with Smad-4 preventing its association with Smad-1. 25 We used an adenoviral infection system to exogenously express Smad-6 during ES cell differentiation. ES cells were infected at day 2 of differentiation with adenoviruses (AdVs) expressing either Smad-6-flag or b-galactosidase, at similar multiplicity of infections (MOIs). The Western blot analysis in Figure 4A shows that the BMP-4 treatment of ES-derived cells induced a strong and sustained phosphorylation of the Smad-1, -5 and/or -8 molecules that was not affected by the infection with the b-galactosidase control AdV. As expected on the contrary, cells infected with the Smad-6 expressing AdV did not respond efficiently to BMP-4 treatment in terms of Smad-1, -5, -8 induced phosphorylation.
A slight toxicity of AdV infection led to a reduced number of cells engaged in the differentiation process since the percentage of differentiated neurofilament-positive ES cells at day 7 was slightly reduced compared to noninfected cells ( Figure 4B ). Nevertheless, infected cells were still able to differentiate into neurofilament-positive neuronal cells with kinetics similar to the uninfected cells ( Figure 4B and C) . 
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BMP-4 induces apoptosis of neural precursor cells
To determine if the ES-derived neural precursor cells are the main target of BMP-4 induced apoptosis, coimmunofluorescence staining was performed with specific antibodies against cleaved caspase-3 along with the neural markers (nestin, NeuN). Because these neural markers appeared only at day 5-6 of differentiation, BMP-4 treatment had to be performed at day 4 instead of day 3. As stated above, detectable spontaneously apoptotic cells were present in cultures even in the absence of BMP-4 ( Figure S3a,b) . However, their proportions dramatically increased in the presence of BMP-4, where all the colonies bearing the neural markers displayed a much higher proportion of cells positive for activated caspase-3 ( Figure S3c,d) . These results suggest that the cell population engaged within the neural pathway is the target of the apoptotic signal induced by BMP-4. However, the neural cells immunostained by the late markers do not colocalized by confocal analysis with the cells stained by the cleaved caspase-3 antibody (not shown). To explain this apparent discrepancy, we hypothesized that only a fraction of cells that are committed to neural fate are the target of BMP-4-induced apoptosis. The Sox-1 molecule is considered as one of the earlier markers for neural precursors. Belonging to the family of the high-mobility group of transcription factors, it is first expressed in the neural plate and subsequently maintained in neuroepithelial cells throughout the entire neuraxis, but is downregulated during neuronal and glial differentiation. 26 Using Sox-1-gfp ES cells, 8 we quantify by flow cytometry the % of Sox-1-positive cells during the differentiation process. As illustrated in Figure 6A , more than 50% of the differentiated ES cells are Sox-1 þ cells at day 4, with a percentage increasing up to 70% by day 6 (not shown). The proportion of Sox-1 positive population decreases severely from 54 to 21% after BMP-4 treatment ( Figure 6A ), representing a loss of 60% of the Sox-1-positive population. When the absolute number of gfp-positive and gfp-negative cells remaining in the cultures before and after BMP-4 treatment was calculated, we observed that the Sox-gfp-positive cells were the main target of the BMP-4 induced apoptosis ( Figure 6B) .
Apoptosis of the Sox-gfp cells was quantified and the results in Figure 6C clearly showed that the percentage of apoptotic Sox-1 positive cells increased upon BMP-4 treatment (from 26 to 57%) while remained similar for the Sox-1 negative cells (from 22.7 to 29%). To further demonstrate that BMP-4 induced apoptotic cell death of neural precursor cells, confocal analysis on ES-derived colonies was performed with Sox-1 and cleaved-caspase-3 antibodies. As expected, a clear colocalization between the two markers was observed as illustrated in Figure 6D .
Finally, as expected, the inhibition of the Smad signalling pathway, through infection of Sox-1-gfp-ES-derived cells with Smad-6 overexpressing AdV, prevented the BMP-4 induced cell death of Sox-1-positive cells. The proportion of Sox-1-positive cells remained stable after BMP-4 treatment of Smad-6-infected cells ( Figure 6E ), while it decreased equally in both noninfected and control LacZ-infected cultures.
Altogether, these results demonstrate that the BMP-4-derived apoptotic signal targets the Sox-1 neural precursor cells developing in this ES-cell differentiation model.
Discussion
In lower vertebrates, BMP-4 is responsible for the inhibition of early neural cell fate determination. 2 Previous studies with ES cells already strengthened the function of BMP-4, in mammals, as a key regulator of the neuroectodermal commitment. Disruption of SMAD-4-mediated BMP/TGF-b signal transduction enhances the ability of ES cells to adopt a neural fate, which is consistent with the suppression of neural differentiation by BMP signaling. 7 Exposure of ES cells to BMP-4 antagonists (recombinant noggin or transfection with a noggin-encoding plasmid) promotes the differentiation of neuro-ectodermal cells. 27 The group of H Kawasaki has demonstrated that BMP-4 is able to redirect neuroectodermal precursors towards epidermal commitment. 6 However, the mechanism of BMP-4 neural inhibition remained unexplored so far. Here, we demonstrate that BMP-4, through the Smad signaling pathway, induces the apoptotic cell death of neuroectodermal precursor cells already engaged in the neural cell fate. And similar to its in vivo effects, BMP-4 activates Msx gene expression and further commits differentiating ES cells toward surface ectodermal lineages.
Interestingly, in our differentiation process, the target cells of BMP-4 were not differentiated neurons but early precursors of neural cells. BMPs have been suggested as general inhibitors of neurogenesis through induction of apoptosis in both the central and peripheral nervous systems. They effectively inhibit proliferation and survival of neocortical BMP-4 induces apoptosis of ES cell-derived neural precursors K Gambaro et al ventricular zone 11, 16 and of cultured sympathetic neuroblasts. 28, 29 This cellular model has been previously used to differentiate rostral CNS tissues containing both ventral and dorsal cells, depending on signals delivered after the initial steps of differentiation. Dopaminergic neurons have been detected between days 6 and 8 of the induction period, following the appearance of Nestin and tubulin markers. 6 Late BMP-4 exposure causes differentiation of neural crest cells and dorsalmost CNS cells, while Sonic hedgehog suppresses differentiation of neural crest lineages and promotes that of ventral CNS tissues such as motor neurons. 30 In these studies 6 and in our hands, only the early exposure to BMP-4 (between day 3 and day 5) led to the inhibition of neural cell differentiation. Here we demonstrate that, even though cells expressing markers of differentiated neural cells (tubulin or NeuN), or even the undifferentiated neural progenitors Nestinpositive cells, were not the target of BMP-4 induced apoptosis, we systematically observed apoptosis in clusters where these markers were expressed. However, by detecting Sox-1, the earliest known specific marker of neuroectoderm in the mouse embryo, 26, 31 we were able to clearly point neural precursors cells as the targets of BMP-4 apoptosis. These results may clarify, at least in part, the molecular basis for BMP-4 inhibition of the neural fate. The question remains on the exact nature of À4 (high statistical representative difference) between untreated and BMP-4 treated cells; * indicates a P-value 40.7 (no statistical representative difference) between untreated and BMP-4 treated cells the surviving precursors that still differentiate into ectodermal/ epidermal cells after BMP-4 treatment. Such committed preneural cells, emerging from a neuroectodermal precursor, have been described in other ES-derived neural differentiation studies. 7, 32 Molecular characterization of these cells would be of interest to study the function of BMP-4 on neuro-ectodermal commitment.
Tested in the presence of Smad-6, BMP-4 no longer prevented neural differentiation of ES cells, demonstrating that in mouse ES cells, inhibition of neural differentiation induced by BMP-4 required the Smad pathway. Furthermore, the BMP-4-dependent apoptotic process was inhibited in Smad-6-infected cells, both at the level of mitochondrial perturbation and the caspase-3 activation. These results demonstrate that BMP-4 requires a functional Smad signaling pathway to induce both apoptosis and neural cell differentiation inhibition.
The apoptotic cell death reported here is characterized by the typical apoptotic mitochondrial damage and the activation of caspase-3. Fujita et al. 33 reported that BMP-4 induces apoptosis of RA-dependent neural differentiating P19 carcinoma cells 34 through the direct activation of caspase-9, upstream of caspase-3 and with no involvement of the classical mitochondrial pathway involving the Apaf-1/cytochrome c complex. In the present model, the broad caspase inhibitor z-VAD-fmk efficiently prevented cell death but was unable to block mitochondrial damage, ruling out a direct activation of the caspase-9 as the mechanism of apoptotic induction by BMP-4. This suggests that activation of caspases occurred downstream of the mitochondrial damage and that apoptosis was not induced through the activation of apical activator caspases (such as caspase-8 activated by Death Effector Domain proteins -FAS, TRAIL or TNF-R family members).
Protein synthesis is required for mitochondrial injury to proceed in our model, indicating that the BMP-4-dependent signaling pathway regulates the transcription of specific genes. Indeed, known genes activated in response to BMP-4 signaling were largely transcribed. Among them, the transcriptional regulator Msx-2 has been reported as a BMP target gene in apoptosis of rhombencephalic neural crest cells, 12 chick limb, 14, 35 calvarial bone 36 and other tissues. 37 The nature of the genes activated by Msx-2 expression and leading to apoptosis are not yet defined. A fine balance between pro-and antiapoptotic molecules, such as Bcl-2 family members, is required to control the integrity of the mitochondrial transmembrane potential. Whether this balance is subjected to regulation by Msx-2 expression can be questionned. For instance, the apoptosis of ventricular zone progenitor cells induced by BMP-4/Msx-2 was suggested to involve bax-independent, as well as bax-dependent cell death pathways, 38 but with no evidence of the relationship between Msx-2 transcription and Bax level modulation. The expression level of such molecules, or their relocalization from or to the mitonchondial membrane, in preliminary tests, do not change during the early steps of the apoptotic mechanism in our conditions (not shown), but further investigation has to be undertaken.
We demonstrate here for the first time the involvement of early neural progenitor apoptotic cell death in the inhibition of neuralization triggered by BMP-4. In vitro ES cell differentiation is a powerful model to study early mammalian development. Based on this model, we propose, here, that, in mammals, BMP-4 controls the fate of ectodermal progenitors -progenitors of both neuroectoderm and surface ectodermtoward the formation of epidermis while inhibiting neural differentiation through an apoptotic mechanism. Such a model will be an invaluable tool to decrypt the full range of molecular events involved.
Materials and Methods
ES cell culture and in vitro differentiation
The undifferentiated mouse ES cell lines CGR8 and CGR8 Sox1 GFP (ES cell line from transgenic mouse in which the enhanced GFP reporter is inserted into the sox1 gene via gene targeting 8 ) were routinely cultured in flasks coated with 0.1% gelatin (GIBCO-BRL, Invitrogen, France) diluted in PBS pH 7.2 (GIBCO-BRL). The culture medium was composed of BHK-21 (GIBCO-BRL) supplemented with 10% fetal bovine serum (Hyclone, Perbio Science, France), 1% nonessential amino acids (GIBCO-BRL), 1 mM sodium pyruvate (GIBCO-BRL), 0.1 mM b-mercaptoethanol (GIBCO-BRL) and 10 3 U/ml LIF (Leukemia Inhibitory Factor, our own production).
For neural differentiation, ES cells were cultured in BHK-21 supplemented with 10% KSR (GIBCO-BRL), 1% nonessential amino acids, 1 mM sodium pyruvate and 0.1 mM b-mercaptoethanol (differentiation medium) on fixed NIH-3T3 cells. It was essential to remove serum from the medium since the addition of fetal bovine serum strongly inhibited neural differentiation.
Formaldehyde treatment of NIH-3T3 cells
NIH-3T3 cells grown to confluency were fixed with 3% formaldehyde in PBS (Sigma-Aldrich, France) for 15 min at room temperature, washed with PBS and incubated with glycine (1 mM) (ICN Pharmaceuticals, France) at room temperature for 15 min to saturate free formaldehyde sites. Dishes or coverslips were stored in PBS at 41C until use for ES cells differentiation.
Treatment with BMP-4 and biochemical inhibitors
ES cells were cultured on fixed NIH-3T3 cells in differentiation medium and 0.5 nM human recombinant BMP-4 (R&D Systems Europe, UK) was added to the medium at the indicated timepoints. For apoptosis assay, BMP-4 was added for 12-18 h on day 3 of differentiation. For epidermal differentiation assays, ES cells were cultured for 8 days and BMP-4 was added each day from day 3 to day 5. PD169316 (1, 3 and 10 mM) (Calbiochem, VWR International SAS, France) and cycloheximide (10 mM) (Sigma-Aldrich) were added 1 h prior to BMP-4 treatment. For caspase inhibition, cells were preincubated for 4 h with z-VAD-fmk (50 mM) (Alexis Corporation, Switzerland).
Antibodies and immunofluorescence
ES cells grown on fixed NIH-3T3 cells (on coated coverslips) for 4 or 8 days in differentiation medium were fixed in PBS-formaldehyde 3% at 41C for 15 min and were then incubated with PBS containing 3% bovine serum albumin (Sigma-Aldrich) for 30 min at room temperature. They were then stained with primary antibodies for 60 min in 3% PBS-BSA, washed, and incubated with secondary antibodies for 60 min in 3% PBS-BSA. The cell 
Confocal microscopy
ES cells cultured on fixed NIH-3T3 cells for 4 days under serum-free conditions were untreated or BMP-4 treated for the last 14 h. Cells were fixed in 3% formaldehyde for 20 min at room temperature, satured and permeabilized with PBS-2.5% donkey serum (Jackson Immuno Research, Interchim, France), 2.5% rabbit serum (Dakko A/S), 0.2% Triton X-100 for 30 min. Permeabilized cells were incubated with rabbit polyclonal anticleaved caspase-3 (Cell Signaling Technologies) and with chicken polyclonal anti-Sox-1 (Chemicon) antibodies in 3% PBS-BSA for 1 h at room temperature. After three washes with PBS 0.2% Triton X-100, cells were incubated with the appropriate fluorescent-conjugated secondary antibodies for 1 h at room temperature. Cells were then washed three times with PBS 0.2% Triton and mounted on glass slides in Mowiol 4-88 (Calbiochem). Slides were finally examined and photographed with a TCS-SP confocal microscope (Leica) using a Â 63 magnification lens.
RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen, France) and incubated with DNase I (Ambion) according to the manufacturer's instructions to minimize genomic DNA contamination. The cDNA was synthesized (2 mg RNA per condition) using the PowerScript Reverse Transcriptase (Clontech, Ozyme, France). The cDNA was analysed by PCR amplification using individual primer pairs for specific marker genes. The following oligonocleotide primer sequences and annealing temperatures were used: 
Real-time quantitative RT-PCR
RNAs were extracted using Trizol reagent (Invitrogen) either 2 or 24 h after stimulation with BMP-4, to measure Msx-1, Msx-2 and Id-3 expression and incubated with DNaseI (Ambion), according to the manufacturer's instructions to minimize genomic DNA contamination. The cDNA was synthesized using the PowerScript Reverse Transcriptase (Clontech, Ozyme). The relative expression level of transcripts was quantified by realtime RT-PCR using the SYBR-Green PCR Master Mix on an ABI PRISM 7700 Sequence Detection System (Applied Biosystems, France), according to the manufacturer's instructions. Each reaction mixture contained a 300 nM concentration of each primer and 5 ml of cDNA product diluted 1 : 25 were used. The relative amount of each gene to 36B4 internal control and the fold stimulation was calculated by using equation (2) ÀDDCT , where DCT ¼ CT gene ÀCT 36B4 and DDCT ¼ DCT stimulated condition ÀDCT unstimulated condition . Each gene was amplified using the appropriate specific primers (sequences available upon request). The results are the average of three separate experiments.
FACS analysis
Neural and epithelial determination ES cells cultured on fixed NIH-3T3 cells were detached with PBS-0.5% BSA-0.5 mM EDTA. They were fixed in 2% formaldehyde in PBS, permeabilized in PBS-0.5% saponin (Sigma-Aldrich)-0.5% BSA for 10 min and saturated with PBS-0.5% saponin-0.5% BSA-0.5% rabbit or swine serum following secondary antibodies for 30 min. They were stained with rabbit antineurofilaments mAb (Affinity Research Products) or with mouse anti-Keratin 18 MAB3234 (Chemicon), mAb for 45 min. Mouse isotype control mAb (PharMingen) and control rabbit serum was used to set the background level of fluorescence. Rabbit anti-mouse and swine anti-rabbit coupled FITC antibodies (Dakko A/S) were added for 45 min. Cells were monitored by flow cytofluorometry on a FACScan system using CellQuest software (BD Biosciences).
DiOC6/IP determination
Mitochondrial injury, leading to the decrease of the mitochondrial transmembrane potential (DCm) is an early and irreversible step in the process of apoptosis. Thus, apoptosis can be measured and quantified by flow cytometric analysis, with the fluorescent probe 3,3 0 dihexyloxacarbocyanine iodide (DiOC 6 (3)), which is a lipophilic cationic fluorochrome that accumulates in the matrix of mitochondria proportionally to their transmembrane potential. A double staining with PI (which labels dead cells that have lost the integrity of their cytoplasmic membrane) and DiOC 6 (3) discriminates between dead cells (DiOC 6 (3) low /PI þ ), live cells (DiOC 6 (3) high /PI À ) and apoptotic cells (DiOC 6 (3) low /PI À ). Differentiated ES cells were detached from the six-well plates and pooled with spontaneously detached cells present in cell culture supernatants. After washing, cells were resuspended in differentiation medium and incubated for 15 min at 371C with 50 nM DiOC 6, (Molecular Probes) and with 5 mg/ml PI (Sigma-Aldrich) at 41C for 5 min. At least 10000 cells were analysed on a FACScan.
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CMXRos determination
Changes in DCm of Sox-1-gfp ES cells were evaluated by cytofluorometry with the potential sensitive red fluorescent probe chloromethyl-X-rosamine (100 nM) (CMXRos, Molecular Probes).
Sox-1-GFP determination
ES Sox-1-GFP cultured on fixed NIH-3T3 cells for 4 days were detached with PBS-0.5% BSA-0.5% mM EDTA, resuspended in cold PBS and counted. They were then analysed by flow cytometry: viable cells were gated according to their size (FCS) and granularity (SSC) and gates were set according to the gfp fluorescence. The % and absolute numbers of Sox-1-gfp-positive cells and gfp-negative cells were determined.
Transient adenoviral infection of smad6 and b-galactosidase genes Adenoviral stocks (obtained from Dr. A Moustakas, Ludwig Institue for Cancer Research, Uppsala, Sweden) were maintained in 293 cells as described by Fujii; 39 their titres ranged from 1 to 4 Â 10 9 plaque forming units (PFU) per millilitre. Infections were performed at a maximal MOI of 6000. Controls were performed using a b-galactosidase-encoding virus and the cells were stained with 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-Gal, Eurogentec, France) as described by Fujii et al. 39 Relatively high MOI had to be used in order to overexpress the Smad-6 as well as the control b-Gal proteins, but the use of similar MOI with similar viruses was published in mammary carcinoma cells. 40 Nevertheless, transgenes were transcribed efficiently ( Figures 4A and 5B) , and despite the slight cell toxicity of the AdV, no perturbation in the commitment to the neural cell lineage was observed ( Figure 4C ). Under optimal conditions, more than 90% of the cells were infected. ES cells were cultured in six-well plates and were infected after 2 days of differentiation for 1 h in a low volume of culture medium. Fresh medium was then added and 48 h after infection, cells were washed and treated with BMP-4.
Immunoblotting
Differentiated ES cells were cultured in 60 mm 2 dishes, treated with BMP-4 and infected as described in the figure legends. Then, the cells were lysed in buffer containing 50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 10 mM leupeptin, 1 mM AEBSF, 100 U/ml aprotinin, 10 mM NaF and 1 mM Na 3 VO 4 . Samples (50 mg of proteins) were resolved by 12% SDS-PAGE, transferred onto Hybond C Extra nitrocellulose membranes (Amersham Biosciences, France), and then incubated with the appropriate antibodies: rabbit polyclonal antibodies raised against the zymogen and the cleaved form of caspase 3 (Cell Signaling Technologies), the phosphosmad-1, -5, -8 (generous gift from Dr C-H Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden), mouse monoclonal antibody raised against Flag M2 (Sigma-Aldrich), mouse ascites fluid raised against btubulin clone TUB2.1 (Sigma-Aldrich), rabbit IgG fraction raised against bgalactosidase (ICN Pharmaceuticals) and mouse monoclonal IgG2b antibody raised against Erk-2 (Santa Cruz Biotechnology, Tebu International). Proteins were visualized with the ECL system (Amersham) using HRP-conjugated anti-rabbit or anti-mouse secondary antibodies.
